mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.3 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.3 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
-0.05 |
0.4 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.045 |
0.4 |